Dialysis Concentrates and Solutions Market Outlook: Rise in Dialysis Session Count to Drive Market Growth to US$ 3.13 Billion by 2031

As per the latest market research by Business Market Insights (BMI), the research report "Dialysis Concentrates and Solutions Market Outlook Size and Forecast (2021–2031)" forecasts how the market is set to surge 46.1% by 2031 as growing dialysis count reshapes dialysis concentrates and solutions ecosystems. The report spotlights governments' role in revolutionizing the global dialysis concentrates and solutions landscape.

The report forecasts the market to expand from US$ 2.14 billion in 2024 to US$ 3.13 billion by 2031, registering a robust CAGR of 5.58% over the 2025–2031 period.

Government support in developing regions acts as a critical driver for the dialysis concentrates and solutions market by addressing key barriers to access and affordability. Recognizing the rising burden of chronic kidney disease (CKD) and end-stage renal disease (ESRD), governments in nations like India and China have implemented national health programs and subsidies to make dialysis services more accessible to a wider population, particularly those in rural or low-income brackets. For instance, India's Pradhan Mantri National Dialysis Programme (PMNDP) provides free-of-cost dialysis to patients below the poverty line, which directly increases the number of dialysis sessions and, consequently, the demand for essential consumables like concentrates and solutions.

Overview of report findings

Market Growth

The Dialysis Concentrates and Solutions Market is projected to grow from US$ 2.14 billion in 2024 to US$ 3.13 billion by 2031, registering a compound annual growth rate (CAGR) of 5.58% between 2025 and 2031.

The customization of dialysis composition, and government support in developing regions are key factors propelling market growth. The increasing number of dialysis sessions globally is transforming the dialysis concentrates and solutions landscape.

Rise in Dialysis Session Count

The rising number of dialysis sessions around the world is a direct and principle driver for the dialysis concentrates and solutions market. Dialysis patients, especially hemodialysis patients, do not receive only one treatment, they require multiple treatments per week or month as a requirement for continuing life. As the prevalence of chronic kidney disease and end-stage renal disease continues to rise, fuelled by populations that are aging, along with diabetes and hypertension, the total number of patients on dialysis will continue to rise, ultimately driving number of sessions higher. Each dialysis session takes a fixed volume of dialysate, which is either mixed form concentrates or pre-mixed solutions. As the number of dialysis patients increase and their treatment becomes more frequent and longer-term, the demand and usage of the drivers to the dialysis treatment will also increase. The growing trend of dialysis sessions is a strong and usable indicator for a sustainable market growth trajectory since it is associated denomination of revenue for suppliers of the dialysis concentrates and solutions.

Customization of Dialysis Composition

The customization of dialysis composition is quickly becoming a key driver for the dialysis concentrates and solutions market, as providers are making a collective move towards more customized treatment options for their patients. As a result of a combination of electrolyte imbalances, comorbidities, or patient tolerance, specific changes to the composition of dialysis solution (including concentrations of sodium, potassium, calcium, and bicarbonate) may be necessary. The increased demand for personalized dosing and formulations of dialysate is incentivizing manufacturers to produce more flexible and customized concentrate solutions, promoting product development and overall market opportunity. In addition, hardware development in dialysis machines that enables on-site or automated customization of dialysate also supports the increased availability of customized solutions, further solidifying the transition towards patient-centred care in nephrology.

Geographic Insights

Due to a well-established healthcare system, higher healthcare expenditure, and a preference for advanced dialysis therapies, North America is recognized as the leading region for dialysis concentrates and solutions market. Favourable government initiatives and reimbursement for dialysis, particularly in the United States, support dialysis market by removing the cost barrier for patients and providers. The region is a front-runner in adopting advanced dialysis systems stimulating usage of dialysis concentrates and solutions.

The Asia-Pacific (APAC) region is the fastest-growing market, driven by its immense and rapidly expanding patient population. The high and rising prevalence of diabetes and hypertension, which are the primary causes of chronic kidney disease (CKD), has created an enormous and escalating demand for dialysis concentrates and solutions.

Market Segmentation

• Based on Product, the market is segmented into Acid Concentrates, Bicarbonate Concentrates, Powdered Concentrates, Dialysate, and Electrolyte Solutions. The Acid Concentrates segment dominated the market in 2024.
• Based on Application, the market is segmented into Hemodialysis and Peritoneal Dialysis. The Hemodialysis segment dominated the market in 2024.

• Based on End User, the market is segmented into In-Center Dialysis Settings and Home Care Settings. The In-Center Dialysis Settings dominated the market in 2024.

Competitive Strategy & Development

Key Players: The Dialysis Concentrates and Solutions Market is populated by several key players, each contributing to its growth and innovation. Some prominent players are:

1. Fresenius Medical Care AG & Co KGaA
2. Baxter International Inc.
3. DaVita Inc.
4. Teleflex Inc
5. B. Braun SE
6. Terumo Corp

Trending Topics: Home-based and portable dialysis, Advancements in automated peritoneal dialysis (APD) technology, Remote patient monitoring and telemedicine, Development of biocompatible dialysate solutions, Innovations in catheter design, Focus on personalized and patient-centric care

Global Headlines

• "Fresenius Medical Care Expands Production of Dry Bicarbonate Concentrate Bags in Brazil- In March 2025, Fresenius Medical Care expanded production of dry bicarbonate concentrate bags in Brazil. The expansion of production for dry bicarbonate concentrate bags addresses the growing demand for convenient and efficient hemodialysis consumables, signalling a focus on expanding supply to meet the rising patient population in Latin America."
• "Fresenius Medical Care Increasing IV, Dialysis Solutions Production to Alleviate Shortages - In October 2024, Fresenius Medical Care increased IV, dialysis solutions production to alleviate shortages. In response to a shortage, company is ramping up production of essential dialysis solutions. This demonstrates the market's sensitivity to disruptions and highlights the crucial role of large-scale manufacturers in ensuring a stable supply of these life-sustaining products, particularly in a crisis or following a natural disaster."

Conclusion

The dialysis concentrates and solutions market continues to grow rapidly because of a rising global demand for customized, patient-specific renal care. A primary factor of this growth is the shift toward personalized medicine, whereby manufacturers are producing more complex concentrates that enable precise customization of dialysate composition. This customization therapy allows clinicians to tailor the solutions to meet patient-specific needs to produce better clinical outcomes and reduce negative side effects, thus improving treatment quality. Additionally, governmental support in developing countries will significantly impact the market. These governments are implementing government policies to subsidize and create access for dialysis treatment and dialysis patients, thereby increasing the number of patients and creating more demand for dialysis and dialysis concentrates and solutions. In addition to the increase in the number of sessions of dialysis around the world due to the rise in the incidence of chronic kidney disease, the growing burden of market is significant. The increase in the incidence of lifestyle diseases including diabetes and hypertension has led to an increase in the patient group that requires regular dialysis treatment, thus there is commercial need for concentrates and solutions. To summarize, the cumulative effect of patient-specific therapy, supportive governmental initiatives, and increasing global burden of renal disease continues to stimulate the dialysis concentrates and solutions market.